BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 6956266)

  • 21. The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet's disease.
    Sano K; Yabuki K; Imagawa Y; Shiina T; Mizuki N; Ohno S; Kulski JK; Inoko H
    Tissue Antigens; 2001 Aug; 58(2):77-82. PubMed ID: 11696219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-B51 frequency in Iranian patients with Behçet's disease.
    Shahram F; Davatchi F; Nadji A; Jamshidi A; Bahar K; Akbarian M; Chams C
    Adv Exp Med Biol; 2003; 528():229-30. PubMed ID: 12918696
    [No Abstract]   [Full Text] [Related]  

  • 23. HLA-B*5101 in Greek patients with Behçet's disease.
    Koumantaki Y; Stavropoulos C; Spyropoulou M; Messini H; Papademetropoulos M; Giziaki E; Marcomichelakis N; Palimeris G; Kaklamanis P; Kaklamani E
    Hum Immunol; 1998 Apr; 59(4):250-5. PubMed ID: 9568801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA and uveitis.
    Feltkamp TE
    Int Ophthalmol; 1990 Oct; 14(5-6):327-33. PubMed ID: 2249910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet's disease.
    Paul M; Klein T; Krause I; Molad Y; Narinsky R; Weinberger A
    Tissue Antigens; 2001 Sep; 58(3):185-6. PubMed ID: 11703827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MICA transmembrane region polymorphism and HLA B51 in Tunisian Behçet's disease patients.
    Ben Ahmed M; Houman H; Abdelhak S; Ben Ghorbel I; Miled M; Dellagi K; Louzir H
    Adv Exp Med Biol; 2003; 528():225-8. PubMed ID: 12918695
    [No Abstract]   [Full Text] [Related]  

  • 27. Familial cases of Behcet's disease.
    Dündar SV; Gençalp U; Simşek H
    Br J Dermatol; 1985 Sep; 113(3):319-21. PubMed ID: 4063168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-B51 negative monozygotic twins discordant for Behçet's disease.
    Gül A; Inanç M; Ocal L; Aral O; Carin M; Koniçe M
    Br J Rheumatol; 1997 Aug; 36(8):922-3. PubMed ID: 9291866
    [No Abstract]   [Full Text] [Related]  

  • 29. Behçet's disease: lack of correlation of clinical manifestations with HLA antigens.
    Müftüoğlu AU; Yazici H; Yurdakul S; Pazarli H; Ozyazgan Y; Tüzün Y; Altaç M; Yalçin B
    Tissue Antigens; 1981 Feb; 17(2):226-30. PubMed ID: 7233417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies.
    de Menthon M; Lavalley MP; Maldini C; Guillevin L; Mahr A
    Arthritis Rheum; 2009 Oct; 61(10):1287-96. PubMed ID: 19790126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathergy test and Behçet's syndrome in Britain.
    Davies PG; Fordham JN; Kirwan JR; Barnes CG; Dinning WJ
    Ann Rheum Dis; 1984 Feb; 43(1):70-3. PubMed ID: 6696521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetics (HLA) of Behçet's disease.
    Mizuki N; Inoko H; Ohno S
    Yonsei Med J; 1997 Dec; 38(6):333-49. PubMed ID: 9509902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies.
    Maldini C; Lavalley MP; Cheminant M; de Menthon M; Mahr A
    Rheumatology (Oxford); 2012 May; 51(5):887-900. PubMed ID: 22240504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenetic studies of Behçet's disease.
    Mizuki N; Ohno S
    Rev Rhum Engl Ed; 1996; 63(7-8):520-7. PubMed ID: 8896070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A complete type patient with Behçet's disease associated with HLA-B*5102.
    Mizuki N; Inoko H; Ishihara M; Ando H; Nakamura S; Nishio M; Ohno S
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):757-8. PubMed ID: 7747590
    [No Abstract]   [Full Text] [Related]  

  • 36. HLA antigens in a Japanese family with Behçet's disease.
    Hayasaka S; Kurome H; Noda S
    Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):589-90. PubMed ID: 8001828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological and molecular HLA typing in Italian Behçet's patients: significant association to B51-DR5-DQw3 haplotype.
    Balboni A; Pivetti-Pezzi P; Orlando P; Rubini M; Selvatici R; Accorinti M; Baricordi OR; Gandini E
    Tissue Antigens; 1992 Mar; 39(3):141-3. PubMed ID: 1598687
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetics of Behçet's disease: lessons learned from genomewide association studies.
    Gül A
    Curr Opin Rheumatol; 2014 Jan; 26(1):56-63. PubMed ID: 24257369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human leukocyte antigen serologic and DNA typing of Behçet's disease and its primary association with B51.
    Mizuki N; Inoko H; Mizuki N; Tanaka H; Kera J; Tsuiji K; Ohno S
    Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3332-40. PubMed ID: 1358857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-Bw51 and Behçet's disease.
    Ohno S; Asanuma T; Sugiura S; Wakisaka A; Aizawa M; Itakura K
    JAMA; 1978 Aug; 240(6):529. PubMed ID: 671660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.